Tivozanib | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tivozanib
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Tivozanib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 2 USDMF, 2 NDC API, 5 Listed Suppliers, $ API Reference Price

7 API Suppliers
2 USDMF
2 NDC API
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 40 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
40 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

6 US Patents, 2 US Exclusivities

6 US Patents
2 US Exclusivities

$ API Ref.Price (USD/KG) : 208,676 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6AVEO PHARMS

filter Patent Number Reset all filters

6 All

01 26821987

02 27166722

03 211504365

filter API Patent Reset all filters

6 All

01 4Y

02 2Blank

filter FDF Patent Reset all filters

6 All

01 4Y

02 2Blank

filter Expiration Date Reset all filters

6 All

01 22024-11-16

02 22025-04-26

03 22039-11-05

Product Main Page

01

AVEO PHARMS

TIVOZANIB HYDROCHLORIDE

BioAsia

Not Confirmed

AVEO PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-04-26

TIVOZANIB HYDROCHLORIDE

US Patent Number : 6821987

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212904

Patent Use Code : U-3100

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AVEO PHARMS

TIVOZANIB HYDROCHLORIDE

BioAsia

Not Confirmed

AVEO PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-04-26

TIVOZANIB HYDROCHLORIDE

US Patent Number : 6821987

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212904

Patent Use Code : U-3100

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AVEO PHARMS

TIVOZANIB HYDROCHLORIDE

BioAsia

Not Confirmed

AVEO PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-11-05

TIVOZANIB HYDROCHLORIDE

US Patent Number : 11504365

Drug Substance Claim :

Drug Product Claim :

Application Number : 212904

Patent Use Code : U-3476

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-11-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AVEO PHARMS

TIVOZANIB HYDROCHLORIDE

BioAsia

Not Confirmed

AVEO PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-11-05

TIVOZANIB HYDROCHLORIDE

US Patent Number : 11504365

Drug Substance Claim :

Drug Product Claim :

Application Number : 212904

Patent Use Code : U-3476

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-11-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AVEO PHARMS

TIVOZANIB HYDROCHLORIDE

BioAsia

Not Confirmed

AVEO PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-11-16

TIVOZANIB HYDROCHLORIDE

US Patent Number : 7166722

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212904

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-11-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

AVEO PHARMS

TIVOZANIB HYDROCHLORIDE

BioAsia

Not Confirmed

AVEO PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-11-16

TIVOZANIB HYDROCHLORIDE

US Patent Number : 7166722

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212904

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-11-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!